Company / Working Capital per Share
Arcadia Biosciences, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.15
FY2025
5-year range
$2.26 / $38.21
FY2021-FY2025
Trend
-39.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 3 consecutive years, from $38.21 in FY2022 to $3.15 in FY2025.
Based on SEC 10-K filings.
3.15 in FY2025 with a 5-year CAGR of +1.4%.
Declined from $18.47 to $3.15 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -56.5%
- 5-Year CAGR
- +1.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2025, working capital per share decreased 39.4% year-over-year.
- Peak working capital per share was recorded in FY2022.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.15 | -39.4% |
| FY2024 | $5.20 | -71.9% |
| FY2023 | $18.47 | -51.6% |
| FY2022 | $38.21 | +1593.3% |
| FY2021 | $2.26 | -23.1% |
| FY2020 | $2.94 | -38.3% |
| FY2019 | $4.76 | -48.7% |
| FY2018 | $9.29 | +79.3% |
| FY2017 | $5.18 | +366.2% |
| FY2016 | $1.11 | -95.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026